Two posters presented at the 2024 American Society of Hematology meeting reported real-world outcomes data for patients ...
The Barbara Ann Karmanos Cancer Institute welcomes José Larios, M.D., transplant hematologist. Dr. Larios is a member of the ...
Dr. Sattva S. Neelapu discusses the intricacies of CAR T-cell therapy treatment and care for patients with hematologic ...
Robert M. Rifkin, MD, FACP, discusses how the MagnetisMM-3 update at the 66th American Society of Hematology Annual Meeting and Exposition sheds light on elranatamab’s role in relapsed/refractory ...
Akriti Jain, MD, discusses her presentation from the 2024 American Society of Hematology Meeting and Exposition.
The top U.S. health official is calling for all alcoholic beverages to carry a warning label about cancer risk.
Tafasitamab increased progression free survival by about 9 months when compared to placebo, according to recent study data.
The Healthy on MSN5d
11 Common Illnesses That Have Been Linked to Alzheimer’sAlthough we don't know a lot about the causes of Alzheimer's disease, the following conditions may raise your risk.
As 2024 begins, many are focusing on healthier diets and fitness resolutions. Is Climate Change Secretly Sabotaging Your 2025 ...
Drinking multiple cups of coffee each day may help prevent cognitive decline in people with a common type of heart rhythm disorder, new research suggests.
Highlights in chronic myeloid leukemia from ASH 2024 include data on efficacy of asciminib over TKIs, benefit from the third-generation TKI olverembatinib, and importance of molecular monitoring.
The randomized phase III AALL1731 trial presented at the American Society of Hematology annual meeting showed that adding the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback